Pfizer's Covid Drug Paxlovid May Reduce the Risk of Developing Long Covid, Study Says
People who took Pfizer’s antiviral treatment Paxlovid shortly after infection saw a 26% lower risk of long Covid compared with those who didn’t, the study said.
Biden Signs Legislation to Declassify Certain Intelligence on Covid Pandemic Origins
Biden signed legislation requiring the declassification of information on any possible links between a lab in China and the origins of the Covid-19 pandemic.
New COVID Origins Data Suggest Pandemic Linked to Raccoon Dogs at Wuhan MarketGenetic material collected at a Chinese market near where the first human cases of COVID-19 were identified show raccoon dog DNA comingled with the virus, suggesting the pandemic may have originated f...
Study Calls COVID's Mental Health Impact ‘Minimal.' The Responses Perfectly Capture 2020
‘It’s a way to speak back to the idea that all harm is measurable,’ according to a psychologist.
FDA Staff Report Says Data Shows Pfizer's Covid Treatment Paxlovid Is Effective in High-Risk Adults
FDA staff said Pfizer’s clinical trial results on its Covid antiviral pill Paxlovid support its use in adults at high risk of progressing to severe disease.